Methyl iodide → HCID 178495088, compound
Reaction equation
[O:1]1[C:5]2[CH:6]=[CH:7][CH:8]=[C:9]([N:10]3[CH2:15][CH2:14][N:13]([CH2:16][CH2:17][CH:18]4[CH2:23][CH2:22][CH:21]([NH:24][C:25](=[O:30])[C:26]([OH:29])([CH3:28])[CH3:27])[CH2:20][CH2:19]4)[CH2:12][CH2:11]3)[C:4]=2[O:3][CH2:2]1.[CH3:31]I>>[O:1]1[C:5]2[CH:6]=[CH:7][CH:8]=[C:9]([N:10]3[CH2:15][CH2:14][N:13]([CH2:16][CH2:17][C@H:18]4[CH2:19][CH2:20][C@H:21]([NH:24][C:25](=[O:30])[C:26]([O:29][CH3:31])([CH3:28])[CH3:27])[CH2:22][CH2:23]4)[CH2:12][CH2:11]3)[C:4]=2[O:3][CH2:2]1Participants
3
Procedure
The title compound, white solid (3 mg, 13.1%), MS (ISP) m/z=432.4 [(M+H)+], was prepared in accordance with the general method of example 62 from N-{4-[2-(4-Benzo[1,3]dioxol-4-yl-piperazin-1-yl)-ethyl]-cyclohexyl}-2-hydroxy-2-methyl-propionamide (20 mg, 47.9 mmol) and methyl iodide.
Sources & evidence
- ORD record
- ord-f784696781dd449eba0c1316e8a41a42
- Source dataset
- uspto-grants-2014_05
- Patent number
- US08722683B2
Reaction notes
Loading…